Silence Therapeutics plc Amortization
Silence Therapeutics plc (SLNCF) reported Amortization of $69.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-08-10
- Silence Therapeutics plc amortization for the quarter ending 2026-06-30 was $35.00K, a 47.76% decline year-over-year.
- Silence Therapeutics plc amortization for the quarter ending 2026-03-31 was $34.00K, a 47.69% decline year-over-year.
- Silence Therapeutics plc amortization for the quarter ending 2025-12-31 was $36.00K, a 43.75% decline year-over-year.
- Silence Therapeutics plc amortization for the quarter ending 2025-09-30 was $75.00K, a 15.38% increase year-over-year.
- Silence Therapeutics plc amortization for fiscal 2025 was $243.00K, a 5.45% decline from fiscal 2024.
- Silence Therapeutics plc amortization for fiscal 2024 was $257.00K, a 1.98% increase from fiscal 2023.
- Silence Therapeutics plc amortization for fiscal 2023 was $252.00K, a 16.13% increase from fiscal 2022.
- Silence Therapeutics plc amortization for fiscal 2022 was $217.00K.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $69.00K 10-Q · filed 2026-08-10 | $105.00K derived: sum of 3 quarters · filed 2026-08-10 | $180.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $34.00K 10-Q · filed 2026-05-07 | $70.00K derived: sum of 2 quarters · filed 2026-05-07 | $145.00K derived: sum of 3 quarters · filed 2026-05-07 | $212.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $111.00K derived: sum of 2 quarters · filed 2026-03-05 | $178.00K derived: sum of 3 quarters · filed 2026-08-10 | $243.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $142.00K derived: sum of 2 quarters · filed 2026-08-10 | $207.00K 10-Q · filed 2025-11-06 | $271.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $132.00K 10-Q · filed 2026-08-10 | $196.00K derived: sum of 3 quarters · filed 2026-08-10 | $261.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $65.00K 10-Q · filed 2026-05-07 | $129.00K derived: sum of 2 quarters · filed 2026-05-07 | $194.00K derived: sum of 3 quarters · filed 2026-05-07 | $258.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $129.00K derived: sum of 2 quarters · filed 2026-03-05 | $193.00K derived: sum of 3 quarters · filed 2026-03-05 | $257.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $129.00K derived: sum of 2 quarters · filed 2025-11-06 | $193.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $128.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $64.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $252.00K 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $217.00K 10-K · filed 2025-02-27 |